-
1
Genome stability of the vaccine strain VAC∆6
Published 2022-07-01“…This necessitates the development of modern safe live vaccines based on VAC using genetic engineering. We created the VACΔ6 strain by transient dominant selection. …”
Get full text
Article -
2
Use of “ARRIAH-AviFluVac” vaccine in turkeys, geese and ducks
Published 2024-09-01“…“ARRIAH-AviFluVac” vaccine against H5 avian influenza was demonstrated to be effective for ducks, geese and turkeys both in the laboratory and production environment. …”
Get full text
Article -
3
Sobre a eficácia da CoronaVac no Twitter: conversações e aspectos políticos
Published 2022-12-01“…A CoronaVac, desenvolvida no Brasil pelo Instituto Butantan em parceria com a Sinovac, manteve-se em meio às disputas políticas que permearam o modo como o nosso país enfrentou a pandemia da COVID-19. …”
Get full text
Article -
4
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
Published 2023-06-01“…This retrospective observational study is aimed to determine the efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac (Sinovac) vaccines against symptomatic or severe disease in COVID-19-diagnosed patients. …”
Get full text
Article -
5
-
6
MANAGEMENT OF A RARE CASE OF PEDIATRIC DEEP STERNAL WOUND INFECTION WITH VACUUM-ASSISTED CLOSURE (VAC)
Published 2022-12-01Subjects: “…vacuum-assisted closure (vac)…”
Get full text
Article -
7
CoronaVac-induced antibodies that facilitate Fc-mediated neutrophil phagocytosis track with COVID-19 disease resolution
Published 2025-12-01“…To fully define the potential immune correlates of Fc-mediated effector functions, we comprehensively analysed the above Fc-mediated effector functions in two study cohorts. In the CoronaVac vaccinee cohort, individuals without breakthrough infection exhibited higher levels of ADCP and ADNP activities with a greater degree of cross-reactivity compared to those who had breakthrough infection. …”
Get full text
Article -
8
Endovascular Treatment of Right Heart Masses Utilizing the AngioVac System: A 6-Year Single-Center Observational Study
Published 2021-01-01“…To describe our institution’s experience with the AngioVac system. Background. Intracardiac and intravascular masses previously required surgical excision, but now, there are a number of minimally invasive options. …”
Get full text
Article -
9
-
10
Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration
Published 2024-01-01Subjects: “…VACS Index…”
Get full text
Article -
11
Relación de los genotipos CagA/VacA del Helicobacter pylori con lesiones precursoras de cáncer gástrico
Published 2021-02-01Subjects: Get full text
Article -
12
Corrigendum: Combining Charlson comorbidity and VACS indices improves prognostic accuracy for all-cause mortality for patients with and without HIV in the Veterans Health Administration
Published 2025-01-01Subjects: “…VACS Index…”
Get full text
Article -
13
-
14
Adverse events and overall health and well-being after COVID-19 vaccination: interim results from the VAC4COVID cohort safety study
Published 2022-06-01“…Objectives To describe the incidence of adverse events (AEs), reactogenicity symptoms, menstrual changes and overall self-rated improvement in health and well-being after COVID-19 vaccination.Design VAC4COVID is an ongoing prospective, active observational, post-authorisation cohort safety study (PASS) of UK-approved vaccines for COVID-19 disease.Setting The study is conducted through a secure website (www.vac4covid.com) by MEMO Research, University of Dundee, UK.Participants 16 265 adult (18 years or older) UK residents with a valid email address and internet access.Interventions Any UK-authorised COVID-19 vaccination.Main outcome measures The outcomes reported in this interim analysis include AEs, reactogenicity-type AEs (headache, fatigue, muscle or joint pain, fever, nausea, dizziness or local vaccine reaction), menstrual changes and reported improvement in overall health and well-being.Results 11 475 consented participants (mean age 54.8 years) provided follow-up data between 2 February and 5 October 2021 (mean follow-up duration 184 days), by which date 89.2% of participants had received two vaccine doses. 89.8% of 5222 participants who completed a follow-up questionnaire in the 7 days after any COVID-19 vaccination reported no AEs. …”
Get full text
Article -
15
To Study the Outcome of Low-Cost Negative-Pressure Wound Therapy Using Wall-Mounted Vacuum Device in the Treatment of Open Wounds
Published 2023-01-01Subjects: “…vac…”
Get full text
Article -
16
Case Report: Fusarium falciforme pericardial and sternal wound infection following orthotopic heart transplantation
Published 2025-01-01Subjects: Get full text
Article -
17
幽门螺杆菌及其vacA 基因亚型和cagA 基因与胃上皮HLA-DR 抗原表达的关系
Published 2002-01-01Subjects: “…螺杆菌/ 幽门/vacA…”
Get full text
Article -
18
A unique Helicobacter pylori strain to study gastric cancer development
Published 2025-01-01Subjects: Get full text
Article -
19
KONCENTRACIONI LOGOR JASENOVAC I KRŠENjE MEĐUNARODNOG PRAVA
Published 2017-03-01Get full text
Article -
20
COVID-19 vaccination and cerebral small vessel disease progression—A prospective cohort study
Published 2025-02-01Subjects: Get full text
Article